This study was to determine the feasibility of using potentiometric stripping analysis (PSA) to measure serum levels of copper, lead, and zinc in elderly subjects with metabolic disorders (hyperglycemia, hypertriglyceridemia, and hypercholesterolemia). Furthermore, we investigated the relationship between serum trace elements and lipid and glucose levels in these patients. There was a strong correlation between serum copper and lead levels in all subjects. Copper levels were significantly higher in subjects with elevated triglycerides and cholesterol, but not blood sugar. Serum zinc concentrations were elevated in hyperglycemic subjects, suggesting a correlation between blood sugar and serum zinc levels. Patients with increased levels of lead and copper, but decreased levels of zinc, had hypertriglyceridemia or hypercholesterolemia. Patients with high levels of zinc, but low levels of lead and copper, were hyperglycemic. These results showed that serum copper and lead levels have important diagnostic value for assessing metabolic disorder and related disease.
M
etallic trace elements are physiologically present in the human body at various concentrations. There are a number of studies investigating the biochemical functions of these elements and their relationship to metabolic disease [1] . For example, zinc and copper have been shown to be essential elements in numerous metabolic reactions [2, 3] . Lead, which has received much publicity regarding its toxicity at high levels, is suspected to be indispensable for myelopoiesis [4] [5] [6] . Given the importance of monitoring the levels of these elements in the population to track health conditions such as metabolic disorders [7] , a simple method for rapidly measuring trace element concentrations in large numbers of samples is needed.
Conventional methods are laborious as they require complicated sample processing before each element can be measured. Reliable measurements of trace element concentrations in blood samples are difficult because of the high concentrations of lipids and proteins present in blood, which interfere with assay tech-niques. Conventional techniques require sample processing before measurements can be made, making them inefficient and laborious. Recently, inductively coupled plasma (ICP) emission spectrometry has been used in many studies because of its ability to measure multiple elements at the same time [8] . However, a large quantity of argon gas and appropriate disposal facilities are necessary when using this method.
Potentiometric stripping analysis (PSA) [9, 10] is an alternative method for determining trace element concentrations that offers several advantages. The trace element concentrations can be rapidly measured directly from body fluids without the need for a gas supply system. Furthermore, simultaneous measurement of multiple trace elements (e.g., cadmium, lead, and copper) is possible using a specifically designed PSA device, the ION 3 analyzer (Steroglass S. R. L., San Martino, Italy). The aim of this study was to determine the sensitivity and efficiency of the ION 3 analyzer for trace element analysis from human serum samples. Serum concentrations of copper, zinc, and lead were measured using ION 3 and compared with serum glucose, triglyceride and cholesterol levels in patients with metabolic disorders.
MAteriAls And Methods
We recruited subjects from Saitama, Japan from 2007-2012, and selected a total of 66 adults (34 male; 32 female; all between 61 and 69 years old) with metabolic disorders (hyperglycemia, or hyperlipidemia). As a result of their illness, all showed slight lipid dysmetabolism or impaired glucose tolerance. All participants were volunteers and gave their written informed consent before participation. This study was approved by the Medical Ethics Committee of the University of Tsukuba (approval number; 553-1).
Subjects were classified into normal or abnormal groups depending on their levels of triglycerides (normal < 150 mg/dL), total cholesterol (normal < 220 mg/dL), or serum glucose (normal < 110 mg/dL). These measurements were performed using Drychem instruments (Fujifilm, Tokyo, Japan). The physical characteristics of these subjects are summarized in Table 1 .
Blood was collected before breakfast (after fasting for at least 12 hours) in trace mineral-free tubes. Blood samples were kept at room temperature for 10-20 min to allow coagulation, and then centrifuged at 3000 rpm for 3 min. One hundred microliters of the supernatant (serum) was collected for subsequent PSA analysis, which was performed using an ION 3.
After performing electrode plating for 1 min using the 0.05 N HCl plating solution, zinc in 100 μL of the serum was measured in 20 mL of buffer [which includes 1 mL of 1 M sodium acetate (pH 4.7) and 19 mL of pure water]. Copper and lead in 100 μL of the serum were measured in 20 mL of buffer (which includes 3 mL of pure 6 M HCl and 17 mL of pure water) after performing in electrode plating for 1 min using 1 N HCl plating solution (HgCl 2 prepared in 1 N HCl). Preliminary tests (data not shown) demonstrated that the ION 3 could detect trace elements from 100 μL serum in 20 mL of buffer solution, which represents a 200-fold dilution.
Standard curves were generated using copper, zinc, and lead standard solutions (1 ppm, Merck, Frankfurt, Germany). Sample concentrations were determined using the standard additions method, with two additions of standard solution (1 ppm control) after each sample addition (100 µL). We then created standard curves using three measurements spots (the sample only, and the two control additions to the sample). Trace element concentrations in the sample were calculated using the settings for the fixed-quantity program of the ION 3. The measurement range (integration range) of the ION 3 was set to the manufacturer's specifications for these trace elements: lead (-471 --400 mV), copper (-364 --196 mV), and zinc (-977 --798 mV). We performed the measurements in duplicate and averaged the results. Total measurement only took approximately 30 min to complete.
To validate our results, we used quality control samples (Serenorm™ Trace Elements Serum, Level 1; SERO201405 and 2; SERO203105, Oslo, Norway) confirmed by the ICP method as a reference for our measurements from serum. The measurements obtained by the PSA method differed within ±10% from those obtained by the ICP method, thus illustrating the accuracy of PSA ( Table 2 ).
All data were statistically analyzed using SPSS, version 13.0 (SPSS Inc., Chicago IL). Because the analysed data had a Gaussian distribution, betweengroup comparisons were made by Student's paired t-test. Correlation coefficients were also calculated to evaluate the relationships between serum trace element concentrations and serum glucose and lipid levels. A P value of less than 0.05 was regarded as statistically significant in consideration of the relatively small number of samples.
results
The participants' serum levels of lead, copper, and zinc are summarized in Tables 3-5 . We could detect statistically significant differences in the participants' lead concentrations. Levels of lead were moderately decreased (1.46-fold) in subjects with hyperglycemia (Table 3) , but were slightly elevated in those with high triglycerides (1.43-fold, Table 4 ) and high cholesterol (1.31-fold, changes in subjects with hyperglycemia (0.68-fold decrease) and hypercholesterolemia (3.52-fold increase). In subjects with hypertriglyceridemia, copper levels also showed a remarkable increase (1.33-fold). Zinc levels were significantly decreased only in subjects with high triglycerides (0.29-fold). Significant changes in serum zinc concentrations were seen in the other subjects, we found that zinc concentrations were decreased 0.59-fold in hypercholesterolemic subjects. Correlation analysis demon-strated a significant positive correlation between serum copper and lead levels (Table 7 ), confirming our above observations. Additionally, we found a positive correlation between copper levels and triglyceride concentrations in our subjects. Triglyceride concentrations were also positively correlated to cholesterol concentration. Glucose levels, however, were negatively correlated to both triglyceride and cholesterol levels. In addition, we applied these trace element analysis for 50 diabetic and 55 non diabetic corpuses from medico-legal autopsy (Table 6 ). Consistent results were obtained by the measurement from autopsy samples.
discussion

Conventional trace element analysis, such as Atomic Absorption Spectrometry (AAS) or Inductively
Coupled Plasma Atomic Emission Spectroscopy (ICP-AES), requires expensive instruments and a gas supply system that makes the measurement process expensive and time-consuming. A simpler and more efficient method is more suitable for the routine analysis of these elements in a clinical setting.
The ION 3 is an extremely sensitive PSA device that is capable of detecting trace elements from complex liquid sources (water, food, chemical, pharmaceutical and oil products) [11] . The computer-assisted potentiometric stripping technique used by the ION 3 is reproducible and can detect very low concentrations of trace elements, often below ppb. Because small amounts of trace elements can be accurately detected and quantified with the ION 3, we assessed the ability of this device to measure these elements efficiently in clinical subjects [12] .
Some problems with this method have been previously reported [13] . One problem is that organic matter, such as the lipid and protein in the sample, can inhibit the electrical characteristics of the trace elements by attaching to the electrode.
However, we can found that diluting the sample 200-fold can minimize the inhibition caused by organic matter in bodily fluids. Therefore, we established that using a sample volume of only 100 microliter in our plating solution was sufficient to acquire stable measurements. Using this method, we can also minimize the consumption of the sample.
We have demonstrated that PSA [14, 15] , using the ION 3 device, is an efficient and accurate way to measure trace elements in blood samples. Using this method, we assessed serum levels of copper, lead and zinc in patients with metabolic disorders (hyperglycemia, hypertriglyceridemia, and hypercholesterolemia).
We found that copper and lead levels were correlated in all samples, suggesting a physiological coregulation of these trace elements may occur in these disorders. We suspected a positive correlation between triglyceride and cholesterol levels, both of which are related to increase cardiovascular disease risk. High glucose concentrations found in hyperglycemic subjects were found to be associated with lower levels of cholesterol.
There was an advanced study about type 2 diabetes and the relations with the trace elements. These observations are consistent with reports that low concentrations of HDL cholesterols may increase the risk of developing type 2 diabetes [16] .
Our findings also demonstrated that subjects with increased serum levels of copper were hyperglycemic and hyperlipidemic. It has previously been shown that high serum copper levels are associated with increased cardiovascular mortality and obesity [17] . The relationship between elevated serum copper concentration and the oxidation of low-density lipoproteins has been indicated [18] . These results may suggest that serum copper and lead levels have important diagnostic value for assessing cardiovascular health.
The results above illustrate an interesting relationship. Subjects with increased levels of lead and copper, but decreased levels of zinc, had hypertriglyceridemia or hypercholesterolemia. Subjects with high levels of zinc, but low levels of lead and copper, were hyperglycemic. The future diagnostic use of PSA for measuring these trace elements will be useful in monitoring the health of these patients [19] [20] .
conclusion
Our results demonstrate the feasibility of potentiometric stripping analysis using ION 3 to accurately and efficiently measure trace elements in blood samples easily. We recommend this method as a reliable way to examine certain metabolic health conditions of patients including corpus submitted to autopsy, even when medical diagnosis was unremarkable. 
